Audera, C., Rocklin, R., Vaillancourt, R., Jakubowski, JA., and Deykin, D. (1988). Altered Arachidonic Acid metabolism and platelet size in atopic subjects. Clin. Immunol. Immunopathol.46(3):352–9.
2.
Basu, DK. and Karmazyn, M. (1987). Injury to rat hearts produced by an exogenous free radical generation system. Study into the role of Arachidonic Acid and eicosanoids. J. Pharmacol. Exp. Ther.242(2):673–85.
3.
Bay, WH., Mishkind, MH., Lane, GE., and Ferris, TF. (1979). The effect of prostaglandin-synthesis stimulation and blockade on sodium excretion at a fixed renal perfusion pressure. J. Lab. Clin. Med.93:78–84.
4.
Bayer, BL., Blass, K.-E., and Forster, W. (1979). Anti-aggregatory effect of prostacyclin (PCI2) in vivo. Br. J. Pharmacol.66:10–12.
5.
Begin, ME., Das, U. N., Ells, G., and Horrobin, DF. (1985). Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukotrienes Med19(2):177–86.
6.
Begin, ME., Ells, G., Das, UN., and Horrobin, DF. (1986). Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J. Natl. Cancer Inst.77(5):1053–62.
7.
Begin, ME., Ells, G., and Horrobin, DF. (1988). Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation.). Natl. Cancer Inst.80(3):188–94.
8.
Bolterman, RJ., Bentley, MD., Sandberg, SM., Fiksen-Olsen, MJ., and Romero, JC. (1989). Effects of atrial natriuretic peptide on renal medullary prostaglandin E2 production. Am. J. Physiol.257:F336–40.
9.
Booyens, J., Engelbrecht, P., le Roux, S., and Louwrens, CC. (1984). Some effects of the essential fatty acids linoleic acid and alpha-linolenic acid and of their metabolites gamma-linolenic acid, Arachidonic Acid, eicosapentaenoic acid, docosahexaenoic acid, and of prostaglandin A, and E, on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukot. Med.15:15–33.
10.
Booyens, J., and van der Merwe, C.F. (1985). Chronic Arachidonic Acid eicosanoid imbalance: A common feature in coronary artery disease, hypercholesterolemia, cancer, and other important diseases. Significance of desaturase enzyme inhibition and of the Arachidonic Acid desaturase-independent pathway. Med. Hypothesis18:53–60.
11.
Borda, ES., de Bracco, M.M., Finiasz, M., and Sterin-Borda, L. (1984). Lymphocytes sensitize rat isolated atria to the inotropic and chronotropic effects of sodium Arachidonate. Br. J. Pharmacol.81:75–83.
12.
Bouclier, M., Luginbuhl, B., Delamadeleine, F., Rossio, P., and Hensby, C. (1989). Repeated application of Arachidonic Acid to the ear of mice: A model of chronic skin inflammation?Agents Actions26(1-2):227–8.
13.
Boudreau, RJ. and Mandin, H. (1981). Effect of Arachidonic Acid and indomethacin on renal function of dogs with pericardial tamponade. Can. J. Physiol. Pharmacol.59(6):586–94.
14.
Boyd, RM., Nasjletti, A., Heerdt, PM., and Baer, PG. (1986). PGI2 synthesis and excretion in dog kidney: Evidence for renal PG compartmentalization. Am. J. Physiol.250:F58–65.
15.
Brenner, RR., Peluffo, RO., Mercuri, O., and Restelli, MA. (1968). Effect of Arachidonic Acid in the alloxan-diabetic rat. Am. J. Physiol.215(1):63–70.
16.
Burch, RM., and Tiffany, CW. (1989). Tumor necrosis factor causes amplification of Arachidonic Acid metabolism in response to interleukin 1, bradykinin, and other agonists. J. Cell. Physiol.141:85–9.
17.
Burstein, S., Gagnon, G., Hunter, SA., and Maudsley, D. V. (1977). Elevation of prostaglandin and cyclic AMP levels by Arachidonic Acid in primary epithelial cell cultures of C3H mouse mammary tumors. Prostaglandins13(1):41–53.
18.
Chow, SL. and Hollander, D. (1978). Arachidonic Acid intestinal absorption: Mechanism of transport and influence of luminal factors on absorption in vitro. Lipids13(11):768–76.
19.
Cook, JA., Wise, WC., and Callihan, CS. (1979). Resistance of essential fatty acid-deficient rats to endotoxic shock. Circ. Shock6:333–42 (secondary reference).
20.
Cook, JA., Wise, WC., Knapp, DR., and Halushka, PV. (1981). Sensitization of essential fatty acid-deficient rats to endotoxin by Arachidonate pretreatment: Role of thromboxane A2. Circ. Shock8:69–76.
21.
Coots, RH. (1965). Metabolism of Arachidonic Acid-1-14C in the rat. J. Lipid Res.6:494–7.
22.
Craven, PA. and De Rubertis, FR. (1988). Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation by unsaturated fatty acids. Gastroenterology95(3):676–85.
23.
Das, UN., Begin, ME., Ells, G., Huang, YS., and Horrobin, DF. (1987). Polyunsaturated fatty acids augment free radical generation in tumor cells in vivo. Biochem. Biophys. Res. Commun.145(1):15–24.
24.
de Clerck, F., Loots, W., Somers, Y., van Gorp, L., Verheyen, A., and Wouters, L. (1985). Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: Inhibition by flunarizine, a Ca2+-overload blocker. Arch. Int. Pharmacodyn.274:4–23.
25.
de Tomas, M.E. and Mercuri, O. (1971). The in vivo incorporation of labeled linoleicacid, α-linolenic acid, and Arachidonic Acid into rat liver lipids. Lipids6(11):787–90.
26.
Didolkar, AK. and Sundaram, K. (1987). Arachidonic Acid is involved in the regulation of h CG-induced steroidogenesis in rat Leydig cells. Life Sci.41(4):471–7.
27.
Dive, D., Moreau, S., and Cacan, M. (1978). Use of a ciliate protozoan for fungal toxins studies. Bull. Environ. Contam. Toxicol.19(4):489–95.
28.
Field, M., Musch, MW., and Stoff, JS. (1981). Role of prostaglandins in the regulation of intestinal electrolyte transport. Prostaglandins21(Suppl.):73–9.
29.
Fish, JE., Ankin, MG., Adkinson, Jr., N.F., and Peterman, VI. (1981) Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects. Am. Rev. Respir. Dis.123(6):609–14.
30.
Frolich, JC., Wilson, TW., Sweetman, BJ., Smigel, M., Nies, AS., Carr, K., Watson, JT., and Oates, JA. (1975). Urinary prostaglandins. Identification and origin. J. Clin. Invest.55:763–70.
31.
Fujimoto, T., Suzuki, H., Tanoue, K., Fukushima, Y., and Yamazaki, H. (1988). Autoradiographic observations of platelets in cerebrovascular injuries induced by Arachidonic Acid and its prevention by ticlopidine. Thromb. Haemost.60(2):319–23.
32.
Hansen, HS. and Jensen, B. (1986). Urinary excretion of arginine-vasopressin and prostaglandin E2 in essential fatty acid-deficient rats after oral supplementation with unsaturated fatty acid esters. J. Nutr.116:198–203.
33.
Henricks, PA.J., van der Tol, M.E., van KATS-Renaud, J.H., Nijkamp, FP., and Verhoef, J. (1984). Differences in the effect of Arachidonic Acid on polymorphonuclear and mononuclear leukocyte function. Biochim. Biophys. Acta801(2):206–14.
34.
Kabara, JJ. (1984). Cosmetic and Drug Preservation Principles and Practice.New York: Marcel Dekker, Inc., pp. 279, 282.
35.
Kaneko, T., Nakano, S.-I., Kaji, K., and Matsuo, M. (1988). Cytotoxicities of autoxidized polyunsaturated fatty acids toward cultured human umbilical vein endothelial cells. Chem. Pharm. Bull.36(10):4203–05.
36.
Karmazyn, M. and Moffat, MP. (1985). Toxic properties of Arachidonic Acid on normal, ischemic, and reperfused hearts. Indirect evidence for free radical involvement. Prostaglandin Leukot. Med.17(2):251–64.
37.
Kinoshita, Y., Romero, JC., and Knox, FG. (1989). Effect of renal interstitial infusion of Arachidonic Acid on proximal sodium reabsorption. Am. J. Physiol.257(2 Pt. 2):F237–42.
38.
Knapp, HR. and Melly, MA. (1986). Bactericidal effects of polyunsaturated fatty acids. J. Infect. Dis.154(1):84–94.
39.
Kohler, C, Wooding, W., and Ellenbogen, L. (1976). Intravenous Arachidonate in the mouse: A model for the evaluation of antithrombotic drugs. Thrombosis Res.9:67–80.
40.
Kohn, A., Gitelman, J., and Inbar, M. (1980). Interaction of polyunsaturated fatty acids with animal cells and enveloped viruses. Antimicrob. Agents Chemother.18(6):962–8.
41.
Lambert, IH. (1987). Effect of Arachidonic Acid, fatty acids, prostaglandins, and leukotrienes on volume regulation in Ehrlich ascites tumor cells. J. Membr. Biol.98(3):207–21.
42.
Landberg, H., Hartmann, A., Vikse, A., and Kiil, F. (1984). Glomerulotubular balance and prostaglandin synthesis. Renal Physiol.7:3–12.
43.
Lauterburg, BH. and Bircher, J. (1976). Expiratory measurement of maximal aminopyrine demethylation in vivo: Effect of phenobarbftal, partial hepatectomy, portacaval shunt and bile duct ligation in the rat. J. Pharmacol. Exp. Ther.196:501–9.
44.
Lee, TH., Mencia-Huerta, J.-M., Shih, C., Corey, EJ., Lewis, RA., and Austen, KF. (1984). Effects of exogenous Arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest.74(6):1922–33.
45.
Lehninger, AL. (1982). Principles of Biochemistry.New York: Worth Publishers, Inc. pp. 305, 595, 746-7, 759.
46.
Leksell, LG. (1978). Effects on fluid balance induced by non-febrile intracerebroventricular infusions of PGE2, PGF2α, and Arachidonic Acid in the goat. Acta Physiol. Scand.104(2):225–231.
47.
Leyssac, P. P. and Christensen, P. (1981). A study of the effect of stimulated endogenous prostaglandin synthesis on urine flow, osmolar excretion rate, and renin release in hydropenic and saline loaded, anesthetized rats. Acta Physiol. Scand.113:23–3.
48.
Liepkalns, VA., Icard-Liepkalns, C., and Cornwell, DG. (1982). Regulation of cell division in a human glioma cell clone by Arachidonic Acid and α-tocopherolquinone. Cancer Lett.15(2):173–8 (Secondary reference).
49.
Maggi, FM., Tyrell, N., Maddox, Y., Watkins, W., Ramey, ER., and Ramwell, P. W. (1980). Prostaglandin synthetase activity in vascular tissue of male and female rats. Prostaglandins19:985–93.
50.
Malmsten, CL. (1986). Prostaglandins, thromboxanes, and leukotrienes in inflammation. Am. J. Med.80(Suppl. 4B):11–17.
51.
Mansour, S. and Daniel, EE. (1986). Maintenance of tone, role of Arachidonate metabolites, and effects of sensitization in guinea pig trachea. Can. J. Physiol. Pharmacol.64(8):1096–1103.
52.
Marshall, LA. (1988). Arachidonic Acid metabolism of cultured peritoneal rat macrophages and its manipulation by nonsteroidal antiinflammatory agents. Immunopharmacology15(3):177–87.
53.
Masaki, DI., Tanna, SM., and Hokama, Y. (1978). Effect of Arachidonic Acid (ARA), prostaglandins E2 (PGE2), and F2a (PGF2α) on sensitized spleen cells in the hemolytic plaque assay. Res. Commun. Chem. Pathol. Pharmacol.22(1):205–8.
54.
Mathe, AA., Strandberc, K., and Yen, A.-S. (1977). Prostaglandin release by slow reacting substance from guinea pig and human lung tissue. Prostaglandins14(6):1105–15.
55.
Mc Giff, JC. (1987). Arachidonic Acid metabolism. Prev. Med.16:503–09.
56.
Mehta, P., Mehta, J., Ostrowski, N., Ross, M., and Player, D. (1985). Arachidonic Acid and isolated human umbilical vein: Concentration-limited prostacyclin generation and absence of direct toxic effects on endothelial integrity. Prostaglandins Leukot. Med.19(2):187–92.
57.
Mercuri, O. and de Tomas, M.E. (1971). Ratio of in vivo incorporation of 3H-Arachidonic Acid and 14C-linoleic acid into liver lipids from normal and diabetic rats. Lipids6(3):203–7.
58.
Morrison, AR. (1986). Biochemistry and pharmacology of renal Arachidonic Acid metabolism. Am. J. Med.80(Suppl. 1A), 3–11.
59.
Myers, AK., Nakanishi, T., and Ramwell, P. (1988). Antagonism of PAF-induced death in mice. Prostaglandins35(3):447–58.
60.
Myers, A., Papadopoulos, A., O'Day, D., Ramey, E., Ramwell, P., and Penhos, J. (1982). Sexual differentiation of Arachidonate toxicity in mice. J. Pharmacol. Exp. Ther.222(2):315–8.
61.
Myers, A., Penhos, J., Ramey, E., and Ramwell, P. (1983). Thromboxane agonism and antagonism in a mouse sudden death model. J. Pharmacol. Exp. Ther.224(2):369–72.
62.
Najid, A., Beneytout, J.-L., and Tixier, M. (1989). Cytotoxicity of Arachidonic Acid and of its lipoxygenase metabolite 15-hydroperoxyeicosatetraenoic acid on human breast cancer MCF-7 cells in culture. Cancer Lett.46(2):137–41.
63.
Nemoto, N. and Takayama, S. (1984). Arachidonic Acid-dependent activation of benzo[a]pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung. Carcinogenesis5(7):961–4.
64.
Palmer, MA., Piper, PJ., and Vane, J.R. (1973). Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea pig lungs. Br. J. Pharmacol.49(2):226–42.
65.
Penhos, J.C, Montalbert-Smith, M., Rabbani, F., Ramey, E., and Ramwell, PW. (1979). Arachidonate induced mortality in male and female mice. Prostaglandins18(5):697–706.
66.
Petry, FM., Tutton, PJ.M., Barkla, DH. (1984). The influence of Arachidonic Acid metabolites on cell division in the intestinal epithelium and in colonic tumors. Prostaglandins Leukot. Med.15(3):349–58.
67.
Puri, S., Belliveau, RE., Spencer, RP., and Bachur, NR. (1975). Prostaglandins in mice neuroblastoma. J. Nucl. Med.16(1):83–5.
68.
Rabbani, F., Meyers, A., Ramey, E., Ramwell, P., and Penhos, J. (1981). Acute protection against Arachidonate toxicity by hydrocortisone and dexamethasone in mice. Prostaglandins21(5):699–704.
69.
Ramesha, CS., Gronke, RS., Sivarajan, M., and Lands, WE.M. (1985). Metabolic products of Arachidonic Acid in rats. Prostaglandins29(6):991–1008.
70.
Rao, GH.R., Gerrard, JM., Eaton, JW., and White, JG. (1978). The role of iron in prostaglandin synthesis: Ferrous iron mediated oxidation of Arachidonic Acid. Prostaglandins Med.1:55–70.
71.
Raychowdhury, Mx, Goswami, R., and Chakrabarti, P. (1985). Effect of unsaturated fatty acids in growth inhibition of some penicillin-resistant and sensitive bacteria. J. Appl. Bacteriol.59(2):183–8.
72.
Rheins, LA., Barnes, L., Amornsiripanitch, S., Collins, CE., and Nordlund, JJ. (1987). Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2. Cell. Immunol.106:33–42.
73.
Rheins, LA. and Nordlund, JJ. (1986). Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity. J. Immunol.136(3):867–76.
74.
Ruzicka, T., and Burg, G. (1987). Effects of chronic intracutaneous administration of Arachidonic Acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. J. Invest. Dermatol.88(2):120–23.
75.
Ruzicka, T. and Printz, M. P. (1982). Arachidonic Acid metabolism in skin: Experimental contact dermatitis in guinea pigs. Int. Arch. Allergy Appl. Immunol.69(4):347–52.
76.
Saksena, SK., Lau, I.-F., and Shaikh, A. A. (1974). Cyclic changes in the uterine tissue content of F-prostaglandins and the role of prostaglandins in ovulation in mice. Fertil. Seteril.25(7):636–43.
77.
Samuelsson, B. (1987). An elucidation of the Arachidonic Acid cascade discovery of prostaglandins, thromboxane, and leukotrienes. Drugs33(Suppl. 1):2–9.
78.
Sananes, N., Baulieu, E.-E., and le Goascogne, C. (1981). A role for prostaglandins in decidualization of the rat uterus. J. Endocrinol.89:25–33.
79.
Schwartzman, ML., Balazy, M., Masferrer, J., Abraham, NC., Mc Giff, J.C, and Murphy, RC. (1987). 12(R)-Hydroxyeicosatetraenoic acid: a cytochrome P450-dependent Arachidonate metabolite that inhibits Na+, K+-ATPase in the cornea. Proc. Natl. Acad. Sci., USA84(22):8125–29.
80.
Sejersted, OM., Vikse, A., Eide, I., and Kiil, F. (1984). Renal venous and urinary PCE2 output during intrarenal Arachidonic Acid infusion in dogs. Acta Physiol. Scand.121:249–59.
81.
Seyberth, HW., Oelz, O., Kennedy, T., Sweetman, BJ., Danon, A., Frolich, JC., Heimberc, M., and Oates, JA. (1975). Increased Arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis. Clin. Pharmacol. Ther, 18(5):521–9.
82.
Siegel, I., Liu, T. L., Yaghoubzadeh, E., Keskey, TS., and Gleicher, N. (1987). Cytotoxic effects of free fatty acids on ascites tumor cells. J. Natl. Cancer Inst.78(2):271–7.
83.
Silver, MJ., Hoch, W., Kocsis, JJ., Ingerman, CM., and Smith, JB. (1974). Arachidonic Acid causes sudden death in rabbits. Science183:1085–87.
84.
Stenson, WF., Nickells, MW., and Atkinson, JP. (1981). Metabolism of exogenous Arachidonic Acid by murine macrophage-like tumor cell lines. Prostaglandins21(5):675–89.
85.
Strub, KM. and Muller, RK.M. (1979). Relation between ulcerogenic activity of various NSAID and their potency as inhibitors of prostaglandin synthesis in vivo. Agents Actions Suppl.4:245–54.
86.
Swell, L. and Law, MD. (1967). Labeling of serum, liver, and testicular lipids following the injection of Arachidonic-1-C14 Acid. (31840) Proc. Soc. Exp. Biol. Med.124(3):739–41.
87.
Takeda, S., Ells, G., Manku, M., Horrobin, D., and Huang, Y.-S. (1989). Cytotoxic effects of polyunsaturated fatty acids against human oral cancer cell lines. FASEB J.3(3, Part 1):A471.
88.
Tannenbaum, J., Splawinski, JA., Oates, JA., and Nies, AS. (1975). Enhanced renal prostaglandin production in the dog. I. Effects on renal function. Circ. Res.36:197–203.
89.
Taylor, AJ., Pandov, HI., Lawson, N. (1987). Determination of erythrocyte fatty acids by capillary gas liquid chromatography. Ann. Clin. Biochem.24:293–300.
90.
Tolnai, S. (1966). Tissue culture and the study of anticancer agents. Can. J. Physiol. Pharmacol.44(2):339–43.
91.
Tragni, E., Caruso, D., Porta, S., Fumagalli, R., Galli, G., and Galli, CL. (1988). Arachidonic Acid metabolism in HEL/30 murine epidermal cell line. Arch. Dermatol. Res.280(7):437–42.
92.
Vargaftig, BB. and Dao, N. (1971). Release of vasoactive substances from guinea pig lungs by slow reacting substance C and Arachidonic Acid. Pharmacology6(2):99–108.
93.
Watanabe-Kohno, S. and Parker, CW. (1980). Role of Arachidonic Acid in the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung fragments: Evidence that SRS-A is very similar or identical structurally to nonimmunologically induced forms of SRS. J. Immunol.125(2):946–55.
94.
Weber, P., Holzgreve, H., Stephan, R., and Herbst, R. (1975). Plasma renin activity and renal sodium and water excretion following infusion of Arachidonic Acid in rats. Eur. J. Pharmacol.34(2):299–304.
95.
Wenzel, DG. and Hale, TW. (1978). Toxicity of free fatty acids for cultured rat heart muscle and endothelioid cells. II. Unsaturated long-chain fatty acids. Toxicology11(2):119–25.
96.
Wilkinson, JB. and Moore, RJ. (1982). Harry's Cosmeticology.New York: Chemical Publishing, p. 44.
97.
Zijlstra, FJ. and Vincent, JE. (1985). Incorporation into the tissues and turnover of Arachidonic Acid after administration to normal and essential fatty acid deficient rats. Prostaglandins Leukot Med.20(3):287–97.
98.
Zoja, C., Perico, N., and Remuzzi, G. (1989). Abnormalities in Arachidonic Acid metabolites in nephrotoxic glomerular injury. Toxicol. Lett.46:65–75.